Reply to Woltsche N. et al. Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single-centre experience

J Eur Acad Dermatol Venereol. 2019 Apr;33(4):e145-e147. doi: 10.1111/jdv.15469. Epub 2019 Mar 20.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anilides
  • Animals
  • Carcinoma, Basal Cell*
  • Hedgehogs
  • Pyridines
  • Skin Neoplasms*

Substances

  • Anilides
  • HhAntag691
  • Pyridines